Adverse Events Up With Immune Checkpoint Blockade Added to Periop Cancer Therapy
Increase seen in incidence of grade 3 to 4 treatment-related adverse events, adverse events leading to treatment discontinuation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.